Operating Lease, Right-of-Use Asset of GT Biopharma, Inc. from 31 Dec 2018 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GT Biopharma, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 31 Mar 2024.
  • GT Biopharma, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2024 was $27,000, a 81% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GT Biopharma, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $27,000 -$113,000 -81% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $53,000 -$112,000 -68% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $87,000 -$103,000 -54% 30 Sep 2023 10-Q 01 Nov 2023 2023 Q3
Q2 2023 $114,000 -$100,000 -47% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 $140,000 -$97,000 -41% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $165,000 -$95,155 -37% 31 Dec 2022 10-K 26 Mar 2024 2023 FY
Q3 2022 $190,000 30 Sep 2022 10-Q 31 Oct 2022 2022 Q3
Q2 2022 $214,000 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $237,000 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $260,155 +$260,155 08 Feb 2022 10-K 30 Mar 2023 2022 FY
Q4 2020 $0 -$110,000 -100% 31 Dec 2020 10-K 16 Apr 2021 2020 FY
Q3 2020 $72,000 -$61,000 -46% 30 Sep 2020 10-Q 13 Nov 2020 2020 Q3
Q2 2020 $80,000 -$67,000 -46% 30 Jun 2020 10-Q/A 18 Aug 2020 2020 Q2
Q1 2020 $95,000 -$58,000 -38% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $110,000 +$110,000 31 Dec 2019 10-K 16 Apr 2021 2020 FY
Q3 2019 $133,000 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 $147,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $153,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-K 27 Mar 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.